Abstract
Transient receptor potential melastatin 8 (TRPM8) is a cold sensory receptor in primary sensory neurons that regulates various neuronal functions. Substance P (SP) is a pro-inflammatory neuropeptide secreted by the neurons, and it aggravates colitis. However, the regulatory role of TRPM8 in SP release is still unclear. Our study aimed to investigate TRPM8’s role in SP release from primary sensory neurons during colitis and clarify the effect of SP on colonic epithelium. We analyzed inflammatory bowel disease patients’ data from the Gene Expression Omnibus dataset. Dextran sulfate sodium (DSS, 2.5%)-induced colitis in mice, mouse dorsal root ganglion (DRG) neurons, ND7/23 cell line, and mouse or human colonic organoids were used for this experiment. Our study found that TRPM8, TAC1 and WNT3A expression were significantly correlated with the severity of ulcerative colitis in patients and DSS-induced colitis in mice. The TRPM8 agonist (menthol) and the SP receptor antagonist (Aprepitant) can attenuate colitis in mice, but the effects were not additive. Menthol promoted calcium ion influx in mouse DRG neurons and inhibited the combination and phosphorylation of PKAca from the cAMP signaling pathway and GSK-3β from the Wnt/β-catenin signaling pathway, thereby inhibiting the effect of Wnt3a-driven β-catenin on promoting SP release in ND7/23 cells. Long-term stimulation with SP inhibited proliferation and enhanced apoptosis in both mouse and human colonic organoids. Conclusively, TRPM8 inhibits SP release from primary sensory neurons by inhibiting the interaction between PKAca and GSK-3β, thereby inhibiting the role of SP in promoting colonic epithelial apoptosis and relieving colitis.
Similar content being viewed by others
Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the intestine with unknown etiology that includes ulcerative colitis (UC) and Crohn’s disease [1]. Recently, the nervous system has been considered to play an important regulatory role in the pathogenesis of IBD [2]. A previous clinical study showed that rectal sensation of bowel distension is reduced in patients with UC [3]. Moreover, surgical cutting of the colonic sensory nerves led to aggravation of 2,4,6-trinitrobenzene sulfonic acid solution (TNBS)-induced colitis in rats [4]. Transient receptor potential (TRP) channels sense temperature changes and nociceptive stimuli and subsequently induce extracellular calcium ion influx [5, 6]. TRP melastatin 8 (TRPM8) is a non-selective ion channel that senses cold (<28 °C), and can be activated by the compounds that induce cold sensation, such as menthol and icilin [7, 8]. TRPM8 is mainly expressed in neurons, especially in primary sensory neurons that are responsible for sensing temperature changes and nociceptive stimuli [8]. Previous study revealed that TRPM8 attenuates TNBS- or dextran sulfate sodium (DSS)-induced colitis in mice [9]. Another experimental study found that the activation of TRPM8 inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) secretion and promotes interleukin-10 (IL-10) secretion by suppressing the mitogen-activated protein kinase (MAPK) pathway in murine macrophages [10]. TRPM8 is highly co-expressed with substance P (SP) in the distal colonic nerve [11]. SP is considered to modulate the immune system and exacerbate intestinal mucosal inflammation during active IBD [12]. Previous studies have demonstrated that the protein level of SP and the expression of its neurokinin-1 receptor (NK-1R) are elevated in the colorectum of IBD patients and are closely related to disease severity [13, 14].
TRPM8 is one of the most important temperature and nociceptive receptors in sensory neurons, and it has the ability to alleviate colitis. However, its effect on colonic primary sensory neurons remains unclear, and may be an important mechanism by which TRPM8 alleviates colitis. Our study elucidates TRPM8 modulatory effects on SP secretion from primary sensory neurons and the effects of SP on colonic epithelial cells, and proposes that menthol and the SP receptor antagonist Aprepitant may serve as therapeutic options for IBD [15].
Results
The role of TRPM8 and TAC1 in colitis
To clarify TRPM8 and TAC1 (encodes SP) expression in patients with UC, we analyzed data from the Gene Expression Omnibus (GEO) dataset. In GSE38713, TRPM8 expression was significantly lower in patients with active UC than in those with inactive UC, whereas TAC1 expression showed the opposite trend (Fig. 1A). Moreover, another study of UC (GSE47908) revealed that TAC1 expression was significantly higher in patients with pancolitis than in those with left-sided colitis and normal individuals, whereas TRPM8 showed the opposite trend (Fig. 1B). To eliminate detection differences, we used the expression value of normal individuals as the standard to perform a fold-change analysis of the datasets (GSE38713, GSE47908, GSE13367, and GSE16879). The analysis showed that TRPM8 and TAC1 have opposite expression in UC: TRPM8 and TAC1 expression were significantly decreased and increased, respectively, in patients with UC (Fig. 1C), which may be positively related to the severity of UC. The expression of TRPM8 and TAC1 in GSE13367 and GSE16879 has been presented in Supplementary Fig. 1. Furthermore, we investigated these trends in experimental colitis models. Compared with control mice, DSS-treated mice had significantly reduced body weight and shortened colon length, and both endoscopic and pathological changes revealed more severe mucosal damage (Fig. 1D–H). Subsequently, we examined gene expression in the two groups. The results showed that Trpm8 and Tac1 expression were significantly decreased and increased, respectively in the DSS-induced colitis group (Fig. 1I). The changes in the expression of these two genes were consistent with the data from IBD patients.
To elucidate the TRPM8 role in colitis, we administered TRPM8 agonist (menthol) and/or antagonist (AMTB) via enema to the DSS-treated mice (Fig. 1J). Compared to the other three groups, the menthol-treated group developed only mild signs of colitis. There was significantly less body weight loss (Fig. 1K) and shorter changes in colon length (Fig. 1L, O) than in the other groups. In addition, endoscopic and histopathological analyses of colonic tissues using H&E staining showed that menthol treatment was accompanied by decreased inflammatory cell infiltration and less destruction of the mucosal epithelial layer in response to DSS treatment (Fig. 1M, N, P). The above results showed that the TRPM8 agonist, menthol, significantly attenuated DSS-induced colitis in mice. Moreover, in the menthol-treated group, Trpm8 expression was significantly increased (Supplementary Fig. 2C), and the expression of inflammatory cytokines such as Tnf, Ifng, and Il23a was significantly decreased (Supplementary Fig. 2A). The serum level of the pro-inflammatory factor, TNF-α, was decreased in the menthol-treated group (Supplementary Fig. 2B). Tac1 gene expression in the colon and serum SP level were significantly decreased in the menthol-treated group (Supplementary Fig. 2D, E). To verify the effect of TRPM8 on SP release from the isolated whole colon, we performed SP release experiments (Supplementary Fig. 3A) [16]. The results showed that menthol significantly inhibited the release of colonic SP, whereas the application of AMTB had the opposite effect (Supplementary Fig. 3B, C).
The activation of TRPM8 inhibits SP release from primary sensory neurons
TRPM8 is highly expressed on primary sensory neurons located in the dorsal root ganglion (DRG) [8]. We examined the calcium ion influx in the DRG neurons induced by the different concentrations of menthol. The results showed that menthol induced calcium ion influx in DRG neurons in a concentration-dependent manner (Fig. 2A, B), with 100 μM menthol having the strongest effect (Fig. 2B, E). Next, we examined the inhibitory effects of different concentrations of AMTB on 100 μM menthol-induced calcium ion influx in DRG neurons. The results showed that the inhibitory effect of AMTB on menthol-induced calcium ion influx was concentration-dependent (Fig. 2C, D), with 10 μM AMTB showing the strongest inhibitory effect (Fig. 2D, F).
Previous single-cell sequencing studies have shown that Trpm8 and Tac1 are co-expressed in the same cell population of DRG neurons [17]. Based on the most effective concentrations in the above results, we used menthol and/or AMTB to stimulate DRG neurons for 6 h. The results showed that menthol significantly promoted Trpm8 expression (Fig. 2G) and inhibited Tac1 expression in DRG neurons (Fig. 2H). Moreover, menthol stimulation markedly reduced the level of SP in the supernatants (Fig. 2H). Taken together, our results suggested that TRPM8 activation can inhibit the TAC1 expression and SP release by primary sensory neurons.
TRPM8 activation may decrease SP release by inhibiting the Wnt/β-catenin signaling pathway in the ND7/23 cell line
The ND7/23 cell line, rat DRG/mouse N18Tg2 neuroblastoma hybridoma cell line, is commonly used for the study of sensory neuron function [18]. However, a previous study showed that Tac1 was expressed at low levels in the ND7/23 cells [19]. Several studies have demonstrated that nerve growth factor (NGF) can promote the production of neuropeptides by inducing ND7/23 cells differentiation [20, 21]. Therefore, we differentiated ND7/23 cells using a neuronal culture medium that was used for DRG neuron culture, containing 50 ng/mL mouse NGF. The results showed that as the number of days of differentiation increased, the protein and mRNA levels of SP increased significantly and TRPM8 protein and mRNA levels decreased significantly (Supplementary Fig. 5A–C). In addition, our study found that the ratio of phosphorylated P38 to total P38 increased (Supplementary Fig. 5D, E), ratio of phosphorylated ERK1/2 to total ERK1/2 decreased, total ERK1/2 increased (Supplementary Fig. 5F, G), and total β-catenin increased (Supplementary Fig. 5H, I) with an increasing number of differentiation days.
To clarify which signaling pathway plays the major role, we further stimulated the differentiated ND7/23 cells with menthol and/or AMTB for 6 h on day 7. Our results showed that TRPM8 protein level and mRNA expression were significantly decreased after differentiation and mRNA expression increased in the menthol-stimulated group (Fig. 3A, B, D). In contrast, SP protein and mRNA expression levels increased after differentiation and significantly decreased in the menthol-stimulated group (Fig. 3A, C, E). Furthermore, no significant difference in the MAPK/ERK pathway was observed (Supplementary Fig. 6A, B), whereas the ratio of phosphorylated P38 to total P38 increased after differentiation and slightly decreased after menthol stimulation (Supplementary Fig. 6C, D). Furthermore, the total β-catenin in the differentiated AMTB-stimulated group increased more than ten-fold compared with the control group and increased more than two-fold compared with the differentiated control group and the menthol-stimulated group (Fig. 3A, F). Moreover, the trend of changes in non-phosphorylated β-catenin was similar to that of β-catenin, while the ratio of non-phosphorylated β-catenin to total β-catenin remained unchanged (Fig. 3A, F). Our study suggested that TRPM8 activation may inhibit SP production by reducing total β-catenin level in ND7/23 cells.
Wnt/β-catenin signaling is upregulated in colitis
Recent study has found that the activation of Wnt/β-catenin signaling pathway in inflammatory bowel disease can promote the expression of pro-inflammatory factors in Treg cells [22]. Earlier study analyzed the expression of WNT ligands and its receptor Frizzled (FZD) in UC patients and found that the expression of WNT ligands was generally increased in UC patients, with the most significant difference in WNT3A expression [23]. In addition, the expression of FZD was also significantly increased in UC patients [23]. To clarify Wnt/β-catenin signaling expression in patients with UC, we analyzed the high-throughput RNA sequencing data (GSE109142) from the Predicting Response to Standardized Pediatric Colitis Therapy (PROTECT) study, which included 20 controls and 206 UC patients [24]. The analysis results showed that the gene expression in the colon tissue of the control group and UC patients was significantly different (Fig. 4A, B), and the expression of WNT3A was increased in UC patients (Fig. 4C). In addition, the analysis also found that the expression of downstream molecules of the Wnt/β-catenin signaling such as FZD2, FZD4, DVL1, CTNNB1, LEF1, and TCF7 was increased in UC patients, while the expression of inhibitory molecules GSK3B and AXIN1/2 was decreased in UC patients (Fig. 4D). Furthermore, our results showed that Wnt3a were significantly upregulated in the DSS-induced colitis group (Fig. 4E).
TRPM8 inhibits Wnt/β-catenin signaling via PKA/GSK-3β interaction
To verify the effect of Wnt3a on the ND7/23 cell line, we stimulated the cells with gradient concentrations of Wnt3a and performed immunoblot. The results showed that Wnt3a significantly increased the level of β-catenin, phosphorylated GSK-3β and SP (Fig. 5A, B), but had no statistical significance on the level of GSK-3β (Supplementary Fig. 7A). In addition, Wnt3a downregulated the Trpm8 expression in ND7/23 cell line (Supplementary Fig. 7B). To clarify how TRPM8 inhibits the Wnt/β-catenin signaling, we stimulated ND7/23 cells with 100 μM menthol or/and 100 ng/ml Wnt3a for 6 h and performed RNA sequencing. The results showed that the different stimuli can dramatically affect gene expression in cells (Fig. 5C). Genes related to adenylate cyclase and sodium-potassium-ATPase were upregulated in Wnt3a group and downregulated in menthol group (Fig. 5D). Through KEGG enrichment analysis, the application of menthol inhibited the cAMP signaling (Fig. 5E), and the application of Wnt3a promoted the cAMP signaling (Fig. 5F), while menthol could inhibit the promoting effect of Wnt3a on the cAMP signaling (Fig. 5G), and Wnt3a could inhibit the calcium signaling induced by menthol (Fig. 5H).
GSK-3β is the main inhibitory molecule in Wnt/β-catenin signaling pathway [25]. PKA is the main molecule of the cAMP signaling pathway [26], among which PKAca is the main catalytic subunit of PKA [27]. We further verified their protein levels under the activation of TRPM8 and/or Wnt3a. The results showed that menthol inhibited the promotion effect of Wnt3a on the protein levels β-catenin and SP (Fig. 5I, J). Under Wnt3a stimulation, menthol decreased the level of phosphorylated GSK-3β and the ratio of phosphorylated GSK-3β to total GSK-3β (Fig. 5K), and had the same inhibitory effect on PKAca (Fig. 5L). In the absence of Wnt3a stimulation, the levels of various proteins were not statistically different among the four groups (Supplementary Fig. 7C–F). The above results proved that there was a clear positive correlation between the phosphorylation degree of GSK-3β and the phosphorylation degree of PKAca on the basis of the activation of Wnt/β-catenin signaling pathway.
In order to clarify whether there is an interaction between PKAca and GSK-3β, we used PKAca and GSK-3β antibodies to immunoprecipitate ND7/23 cell lysates and performed immunoblot. We found that phosphorylated GSK-3β protein was present in the immunoprecipitation group using PKAca antibody, and phosphorylated PKAca protein was also present in the immunoprecipitation group using GSK-3β antibody (Fig. 5M). We next performed immunoprecipitation and immunoblot on menthol and/or Wnt3a-stimulated ND7/23 cells. The results showed that all four groups had the combination of PKAca and GSK-3β, and in the PKAca and GSK-3β immunoprecipitation groups, menthol inhibited the combination of PKAca and GSK-3β under the action of Wnt3a (Fig. 5N, O). In addition, menthol decreased the level of phosphorylated GSK-3β in the corresponding input group (Fig. 5N, O). The above results demonstrated that phosphorylated PKAca and GSK-3β can be combined with each other, which explains the positive correlation phenomenon of their phosphorylation degree.
SP inhibits proliferation and promotes apoptosis of colonic organoids
The nerve endings of primary sensory neurons are distributed in the submucosa of the colon, and they secrete neuropeptides such as SP [28]. The SP receptor NK-1R is highly expressed in the colonic epithelium and is upregulated in IBD patients [14]. To observe the effect of SP on the colonic epithelium, we stimulated mouse colonic epithelial organoids with SP (1 μM) for 8 days and performed propidium iodide (PI) staining to indicate apoptosis. Our study found that SP inhibited the growth of colonic epithelial organoids and promoted their apoptosis (Fig. 6A). The area fold-change curves indicated that the organoids stopped growing after day 3, and the difference was significant (Fig. 6B). Similar effects were observed by stimulating colonic organoids with different concentrations of SP (100 nM and 1 μM) for 48 h (Fig. 6C). To clarify the role of SP in the proliferation and apoptosis of mouse colonic epithelial organoids, we performed Ki67, TUNEL, and PI staining. The results showed that SP stimulation decreased the number of Ki67-positive cells (Fig. 6D) and increased the number of TUNEL-positive particles (Fig. 6E), with a statistically significant difference (Fig. 6F). The PI staining images showed that SP significantly promoted apoptosis in mouse colonic organoids (Fig. 6G).
To verify the effect of SP on human colonic epithelium, we stimulated human colonic organoids with SP (1 μM) for 48 h and performed microscopy and staining. The results showed that SP inhibited the growth of human colonic organoids (Fig. 7A), and organoids in the SP-stimulated group were significantly smaller than those in the control group (Fig. 7B). On the other hand, the staining showed that the number of Ki67-positive cells in human colonic organoids significantly decreased after SP stimulation (Fig. 7C, D), with smaller organoids (Fig. 7C). In contrast, the number of TUNEL-positive particles in SP-stimulated organoids were increased (Fig. 7E, F), and the 3-dimensional structure of the organoids was destroyed (Fig. 7E). Collectively, these results indicated that SP may aggravate IBD or DSS-induced colitis in mice by inhibiting proliferation and promoting apoptosis of colonic epithelial cells.
The SP receptor antagonist Aprepitant and menthol can both alleviate colitis in mice but the effects are not additive
Presently, SP receptor NK-1R antagonist (Aprepitant) has been utilized in the treatment of chemotherapy-induced nausea and vomiting [15], and could be used to relieve cough in lung cancer [29]. If the effect of Aprepitant in colitis is determined, Aprepitant could be regarded as a potential drug for IBD treatment. In addition, comparing the therapeutic effects of menthol, Aprepitant, and Aprepitant plus menthol in colitis can clarify whether they have a direct relationship. In the drinking water negative control groups or during DSS-induced colitis modeling in mice, menthol was given by enema and Aprepitant was given by intraperitoneal injection (Fig. 8A). Compared with drug application groups and negative control groups, the DSS group had more severe colitis symptoms, significantly reduced body weight (Fig. 8B, C), and significantly shortened colon (Fig. 8D, E), while there was no significant difference between the negative control groups (Fig. 8B–E). In addition, histopathological analyses of colonic tissues using H&E staining revealed significant infiltration of inflammatory cells and destruction of mucosal epithelial layer in the DSS group (Fig. 8F, G). However, there were no significant differences in body weight, colon length, inflammatory cell infiltration, and epithelial disruption among the drug-applied DSS groups (Fig. 8B–G). Experiments shown that both TRPM8 agonist menthol and SP receptor antagonist Aprepitant could alleviate colitis in mice, but they could not be superimposed, which verifies the role of TRPM8 in attenuating colitis by inhibiting SP release.
Discussion
The sensory nervous system plays important role in IBD pathogenesis. TRP channels are nociceptors and temperature receptors in primary sensory neurons that regulate the secretion of neuropeptides [30]. TRPM8 is a cold-sensory receptor, and its specific agonist, menthol, is a widely used food additive and is found in traditional Chinese medicine [31,32,33]. Previous study reported that the activation of TRPM8 inhibited the release of the pro-inflammatory factor TNF-α in macrophages through the MAPK pathway and promoted the release of the anti-inflammatory factor, IL-10 [10]. Our study identified a different mechanism whereby TRPM8 activation can inhibit the secretion of the pro-inflammatory neuropeptide SP from the colonic primary sensory neurons [34].
TRPM8 induces calcium ion influx in primary sensory neurons and affects various cellular functions. In macrophages, TRPM8 regulates MAPK signaling pathways such as MAPK/ERK and MAPK/P38 [10]. Another study showed that TRPM8 activation can inhibit the development of colorectal cancer by suppressing the Wnt/β-catenin signaling pathway [35]. Our study discovered for the first time that the activation of TRPM8 mainly inhibited the SP release from primary sensory neurons via Wnt/β-catenin signaling pathway. In addition, we found that Wnt3a, a ligand of the Wnt/β-catenin signaling pathway, was upregulated in the lesion tissues of IBD patients and colitis mice, and TRPM8 can inhibit the combination of PKAca molecule of cAMP signaling pathway and GSK-3β molecule of Wnt/β-catenin signaling pathway, thereby inhibiting GSK-3β phosphorylation. GSK-3β is the main inhibitory molecule of Wnt/β-catenin signaling pathway, which is inactivated by degradation after phosphorylation [25]. Unphosphorylated GSK-3β can phosphorylate β-catenin, thereby promoting the degradation of β-catenin and inhibiting its translocation into the nucleus to regulate transcription [25].
Colonic epithelial barrier function is impaired in IBD and the SP receptor NK-1R is expressed in the epithelial cells [36, 37]. Several studies have shown that short-term (6–24 h) stimulation of SP can inhibit apoptosis in the colonic epithelial cell line NCM460 [38, 39]. Another study found that long-term (48 h) stimulation of SP can induce apoptosis in B16F10 melanoma cells [40]. Similarly, our study revealed that SP stimulation for less than 24 h had no significant effect on the growth of mouse colonic organoids, whereas SP stimulation for 48 h inhibited proliferation and promoted apoptosis of mouse and human colonic organoids. Our results indicated that the effect of SP on colonic epithelium was time dependent. IBD is a chronic inflammatory disease, the long-term stimulation of SP may be closer to the pathogenesis of IBD, and SP may aggravate the severity of IBD by promoting colonic epithelial cell apoptosis. SP receptor NK-1R antagonist (Aprepitant) has been used clinically to treat nausea, vomiting and cough [15, 29]. Our study found that menthol and Aprepitant have clear therapeutic effects on DSS-induced colitis in mice, and they can be regard as potential therapeutic drugs for IBD. These two substances have no obvious toxic and side effects on the human body, and further relevant clinical trials should be carried out. Our research mainly focused on mouse model experiments, so the regulatory effect of TRPM8 on SP release in colonic tissues of patients with IBD should be further studied.
Collectively, our study showed that the expression levels of TRPM8, TAC1, WNT3A were correlated with the severity of IBD. The activation of TRPM8 attenuated DSS-induced colitis in mice. Menthol-induced calcium influx of TRPM8 can inhibit the combination of PKAca from the cAMP signaling pathway and GSK-3β from the Wnt/β-catenin signaling pathway, thereby inhibiting the role of β-catenin in promoting the release of SP from primary sensory neurons. Our study also found that long-term SP stimulation inhibited proliferation and promoted apoptosis in mouse and human colonic epithelial organoids. Both the TRPM8 agonist menthol and the SP receptor antagonist Aprepitant can attenuate colitis in mice, but the effects were not additive.
Materials and methods
Experimental animals
8–12 weeks old C57BL/6 mice were purchased from Model Organisms Center. All animal experiments were approved by the Biological Research Ethics Committee of the Tongji University (Permit Number: TJBB05523101). Mice were administered 2.5% DSS (MP Biomedicals) to induce colitis [10]. Menthol was dissolved and stored in DMSO at 100 mM and administrated as 125 μg/kg body weight [10]. Aprepitant was performed as 3 mg/kg body weight [41].
Histological analysis of colitis
Colitis severity was determined by assessing the sum (range, 0–6) of the scores (range, 0–3) for the degree of tissue damage and lamina propria inflammatory cell infiltration [42].
Dorsal root ganglion isolation and stimulation
The mice dorsal root ganglion (DRG) was dissected and dissociated, as previously described [43, 44].
Ratiometric (Ca2+)i measurements
Ratiometric (Ca2+)i measurements were performed using a Fluo-4 Calcium Imaging Kit (Thermo Fisher, New York, USA) [45].
Colonic crypt isolation and organoid culture
The specific experimental procedure has been described previously and the details was in the online supplementary methods [43].
Substance P release from isolated mouse colon
The details of the experimental procedure were performed as Engel M.A.’s previous study and see online supplementary methods for details [16, 46, 47].
Statistical analysis
All results are presented as the mean ± standard error of the mean (SEM). The number (n) quoted throughout the manuscript refers to the number of mice, isolated DRG neurons, colonic organoids, or experimental repetitions. The t-test was used to compare two groups, and one-way ANOVA and Tukey’s multiple comparisons test were used to compare more than two groups to determine the statistical significance. All results were calculated using GraphPad Prism V9: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Data availability
All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials. The RNA-sequencing data presented in this article have been submitted to the NCBI Gene Expression Omnibus database under accession number GSE242559.
References
Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol. 2021;56:489–526.
Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144:36–49.
Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut. 2000;47:497–505.
Takami Y, Mantyh CR, Pappas TN, Takahashi T, Koda K, Miyazaki M. Extrinsic surgical denervation ameliorates TNBS-induced colitis in rats. Hepatogastroenterology. 2009;56:682–6.
Caterina MJ, Pang Z. TRP channels in skin biology and pathophysiology. Pharmaceuticals. 2016;9:77.
Nilius B, Owsianik G. The transient receptor potential family of ion channels. Genome Biol. 2011;12:218.
Ledford H, Callaway E. Medicine Nobel goes to scientists who discovered biology of senses. Nature. 2021;598:246.
Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature. 2007;448:204–8.
Ramachandran R, Hyun E, Zhao L, Lapointe TK, Chapman K, Hirota CL, et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci USA. 2013;110:7476–81.
Khalil M, Babes A, Lakra R, Försch S, Reeh PW, Wirtz S, et al. Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 production. Mucosal immunology. 2016;9:1500–13.
Hosoya T, Matsumoto K, Tashima K, Nakamura H, Fujino H, Murayama T, et al. TRPM8 has a key role in experimental colitis-induced visceral hyperalgesia in mice. Neurogastroenterol Motil. 2014;26:1112–21.
Weinstock JV. Substance P and the regulation of inflammation in infections and inflammatory bowel disease. Acta Physiol. 2015;213:453–61.
Vento P, Kiviluoto T, Keranen U, Jarvinen HJ, Kivilaakso E, Soinila S. Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis. J Histochem Cytochem. 2001;49:749–58.
Goode T, O’Connell J, Anton P, Wong H, Reeve J, O’Sullivan GC, et al. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut. 2000;47:387–96.
Zhang L, Lu S, Feng J, Dechaphunkul A, Chang J, Wang D, et al. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). Ann Oncol. 2018;29:452–8.
Engel MA, Leffler A, Niedermirtl F, Babes A, Zimmermann K, Filipovic MR, et al. TRPA1 and substance P mediate colitis in mice. Gastroenterology. 2011;141:1346–58.
Li CL, Li KC, Wu D, Chen Y, Luo H, Zhao JR, et al. Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity. Cell Res. 2016;26:83–102.
John VH, Main MJ, Powell AJ, Gladwell ZM, Hick C, Sidhu HS, et al. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. Neuropharmacology. 2004;46:425–38.
Yin K, Baillie GJ, Vetter I. Neuronal cell lines as model dorsal root ganglion neurons: a transcriptomic comparison. Mol Pain. 2016;12:1744806916646111.
Inoue A, Ohnishi M, Fukutomi C, Kanoh M, Miyauchi M, Takata T, et al. Protein kinase A-dependent substance P expression by pituitary adenylate cyclase-activating polypeptide in rat sensory neuronal cell line ND7/23 cells. J Mol Neurosci. 2012;48:541–9.
Haberberger RV, Barry C, Matusica D. Immortalized dorsal root ganglion neuron cell lines. Front Cell Neurosci. 2020;14:184.
Quandt J, Arnovitz S, Haghi L, Woehlk J, Mohsin A, Okoreeh M, et al. Wnt-β-catenin activation epigenetically reprograms T(reg) cells in inflammatory bowel disease and dysplastic progression. Nat Immunol. 2021;22:471–84.
You J, Nguyen AV, Albers CG, Lin F, Holcombe RF. Wnt pathway-related gene expression in inflammatory bowel disease. Dig Dis Sci. 2008;53:1013–9.
Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019;10:38.
Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.
Zhang H, Kong Q, Wang J, Jiang Y, Hua H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol. 2020;9:32.
Cao B, Lu TW, Martinez Fiesco JA, Tomasini M, Fan L, Simon SM, et al. Structures of the PKA RIα holoenzyme with the FLHCC Driver J-PKAcα or wild-type PKAcα. Structure. 2019;27:816–828.e4.
Khalil M, Zhang Z, Engel MA. Neuro-immune networks in gastrointestinal disorders. Visc Med. 2019;35:52–60.
Smith JA, Harle A, Dockry R, Holt K, Russell P, Molassiotis A, et al. Aprepitant for cough in lung cancer. a randomized placebo-controlled trial and mechanistic insights. Am J Respir Crit Care Med. 2021;203:737–45.
Koivisto AP, Belvisi MG, Gaudet R, Szallasi A. Advances in TRP channel drug discovery: from target validation to clinical studies. Nat Rev Drug Discovery. 2022;21:41–59.
Berman ML, Jenson D. The food and drug administration as gatekeeper and the menthol exemption. Am J Public Health. 2020;110:775–6.
Fu S, Cheng R, Deng Z, Liu T. Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS. J Pharm Anal. 2021;11:709–16.
Gao C, Liang J, Zhu Y, Ling C, Cheng Z, Li R, et al. Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy. Acta Pharm Sin B. 2019;9:843–57.
Green DP, Limjunyawong N, Gour N, Pundir P, Dong X. A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron. 2019;101:412–420.e3.
Pagano E, Romano B, Cicia D, Iannotti FA, Venneri T, Lucariello G, et al. TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/beta-catenin signalling. Br J Pharmacol. 2022;180:235–51.
Parikh K, Antanaviciute A, Fawkner-Corbett D, Jagielowicz M, Aulicino A, Lagerholm C, et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. Nature. 2019;567:49–55.
Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016;73:4249–64.
Koon HW, Zhao D, Zhan Y, Moyer MP, Pothoulakis C. Substance P mediates antiapoptotic responses in human colonocytes by Akt activation. Proc Natl Acad Sci USA. 2007;104:2013–8.
Koon HW, Zhao D, Zhan Y, Rhee SH, Moyer MP, Pothoulakis C. Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells. J Immunol. 2006;176:5050–9.
Zhou J, Geng KK, Ping FF, Gao YY, Liu L, Feng BN. Cross-talk between 5-hydroxytryptamine and substance P in the melanogensis and apoptosis of B16F10 melanoma cells. Eur J Pharmacol. 2016;775:106–12.
Utsumi D, Matsumoto K, Amagase K, Horie S, Kato S. 5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis. Br J Pharmacol. 2016;173:1835–49.
Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12:1295–309.
Zhang Z, Engel MA, Koch E, Reeh PW, Khalil M. Menthacarin induces calcium ion influx in sensory neurons, macrophages and colonic organoids of mice. Life Sci. 2021;264:118682.
Pinho-Ribeiro FA, Baddal B, Haarsma R, O’Seaghdha M, Yang NJ, Blake KJ, et al. Blocking neuronal signaling to immune cells treats streptococcal invasive infection. Cell. 2018;173:1083–97 e22.
Wen H, Hubbard JM, Rakela B, Linhoff MW, Mandel G, Brehm P. Synchronous and asynchronous modes of synaptic transmission utilize different calcium sources. eLife. 2013;2:e01206.
Roza C, Reeh PW. Substance P, calcitonin gene related peptide and PGE2 co-released from the mouse colon: a new model to study nociceptive and inflammatory responses in viscera, in vitro. Pain. 2001;93:213–9.
Mueller-Tribbensee SM, Karna M, Khalil M, Neurath MF, Reeh PW, Engel MA. Differential Contribution of TRPA1, TRPV4 and TRPM8 to Colonic Nociception in Mice. PLoS ONE. 2015;10:e0128242.
Acknowledgements
We appreciate the academic support from Translational Medicine Platform of Shanghai East Hospital. The RNA libraries were sequenced on the illumina NovaseqTM 6000 platform by OE Biotech, Inc., Shanghai, China. We are grateful to OE Biotech, Inc. (Shanghai, China) for assisting in sequencing and/or bioinformatics analysis.
Funding
This work was supported by the National Natural Science Foundation of China (grant numbers: 82200613, 82072684, 82073224, and 82300642), Shanghai Committee of Science and Technology (grant numbers: 22YF1436400, 20XD1402900, 21XD1423100, and 21JC1405200), Shanghai Pujiang Program (grant number: 2022PJD015), China Postdoctoral Science Foundation (grant number: 2022M722414), Development Fund for Shanghai Talents (grant number: 2020076), Municipal Health Commission of Pudong New Area (grant number: PW2021B-11), Key Disciplines Group Construction Project of Shanghai Pudong New Area Health Commission (grant number: PWZxq2022-06), and The Top-level Clinical Discipline Project of Shanghai Pudong (grant number: PWYgf2021-02).
Author information
Authors and Affiliations
Contributions
Conceptualization: Zehua Z, LK, XY, MX, TC. Data curation: Zehua Z, Zhuyun L, LK, XY, AF, ZC, SZ, Ziying Z. Formal analysis: Zehua Z, Zhuyun L, LK, XY, SY, YJ, XD, KF, ZW, Zhaoxing L, MS. Funding acquisition: Zehua Z, LK, XY, MX, TC. Project administration: Zehua Z, LK, MX, TC. Validation: Zehua Z, Zhuyun L, XY, SY, YJ, XD, KF, ZW, Zhaoxing L, MS, Ziying Z, DW. Methodology: Zehua Z, Zhuyun L, LK, KF, ZW, Zhaoxing L, MS, DW. Investigation: Zehua Z, Zhuyun L, XY, AF, ZC, SZ, Ziying Z. Visualization: Zehua Z, Zhuyun L, LK, AF, ZC, SZ, DW. Supervision: MX, TC. Writing—original draft: Zehua Z, LK. Writing—review & editing: Zhuyun L, XY, MX, TC.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
The animal research was performed under the protocol that has been approved by the Biological Research Ethics Committee of the Tongji University (Permit Number: TJBB05523101). The collection of human colonic biopsies was approved by the Ethics Committee of East Hospital Affiliated to Tongji University (Permit Number: 2021-017).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Professor Anastasis Stephanou
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, Z., Yan, X., Kang, L. et al. TRPM8 inhibits substance P release from primary sensory neurons via PKA/GSK-3beta to protect colonic epithelium in colitis. Cell Death Dis 15, 91 (2024). https://doi.org/10.1038/s41419-024-06480-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-024-06480-5
- Springer Nature Limited